Takehiro Nakahara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takehiro Nakahara has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Masahiko Kurabayashi
Departments of Medicine and Biological Science
15 shared publicationsJagat Narula
University of Texas Health-McGovern Medical School, Houston, USA
9 shared publicationsMasahiro Jinzaki
Department of Radiology, Keio University School of Medicine, Tokyo, Japan
8 shared publications- Harry William Strauss
Memorial Sloan-Kettering Cancer Center
7 shared publications H. William Strauss
Memorial Sloan Kettering Cancer Center, New York, USA
6 shared publications- Jagat Narula
McGovern Medical School, University of Texas Health Sciences Center, Houston, Texas, USA
6 shared publications
Latest Publications
- Open Access
- 5 April 2026
- Published by Springer Nature in EJNMMI Physics
- Vol. 13 (1)
Intravascular position-sensitive positron-counting catheter for atherosclerotic plaques
Rupture prone high-risk atheromatous plaques are characterized by large necrotic core volumes covered by thin fibrous caps which are positively remodeled;
- 5 April 2026
- Published by Springer Nature in EJNMMI Physics
- Vol. 13 (1)
Open AccessIntravascular position-sensitive positron-counting catheter for atherosclerotic plaques
Rupture prone high-risk atheromatous plaques are characterized by large necrotic core volumes covered by thin fibrous caps which are positively remodeled;
- Open Access
- 6 February 2025
- Published by Elsevier in Journal of Cardiology
- Vol. 85 (5) , 386-398
Molecular imaging of cardiovascular disease: Current status and future perspective
- 6 February 2025
- Published by Elsevier in Journal of Cardiology
- Vol. 85 (5) , 386-398
Open AccessMolecular imaging of cardiovascular disease: Current status and future perspective
- 1 September 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (9) , 1975-1985
Aortic Uptake of 18 F-NaF and 18 F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy
BACKGROUND: Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of 18 F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether 18 F-FDG and 18 F-NaF uptake was predictive of abdominal aortic aneurysm expansion. METHODS: Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography–computed tomography with 18 F-FDG and 18 F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl 2 or saline stimulation. In the 1-week cohort (n=25), the correlation between 18 F-FDG or 18 F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential 18 F-FDG and 18 F-NaF uptake or calcification volume was examined. RESULTS: In the 1-week cohort, the maximum standard unit value of 18 F-FDG and 18 F-NaF uptake correlated with CD68- (r=0.82; P =0.001) and von Kossa staining–positive areas (r=0.89; P 18 F-FDG and 18 F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, 18 F-FDG showed high uptake at weeks 1 and 2, whereas a high 18 F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with 18 F-FDG and 18 F-NaF uptake and calcification volume, especially at 1 and 2 weeks ( 18 F-NaF [1 week]: r=0.61, 18 F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; P 18 F-NaF uptake at 1 week being the strongest predictor. CONCLUSIONS: The uptake of 18 F-NaF and 18 F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with 18 F-NaF uptake being the strongest predictor.
- 1 September 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (9) , 1975-1985
Aortic Uptake of 18 F-NaF and 18 F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy
BACKGROUND: Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of 18 F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether 18 F-FDG and 18 F-NaF uptake was predictive of abdominal aortic aneurysm expansion. METHODS: Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography–computed tomography with 18 F-FDG and 18 F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl 2 or saline stimulation. In the 1-week cohort (n=25), the correlation between 18 F-FDG or 18 F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential 18 F-FDG and 18 F-NaF uptake or calcification volume was examined. RESULTS: In the 1-week cohort, the maximum standard unit value of 18 F-FDG and 18 F-NaF uptake correlated with CD68- (r=0.82; P =0.001) and von Kossa staining–positive areas (r=0.89; P 18 F-FDG and 18 F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, 18 F-FDG showed high uptake at weeks 1 and 2, whereas a high 18 F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with 18 F-FDG and 18 F-NaF uptake and calcification volume, especially at 1 and 2 weeks ( 18 F-NaF [1 week]: r=0.61, 18 F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; P 18 F-NaF uptake at 1 week being the strongest predictor. CONCLUSIONS: The uptake of 18 F-NaF and 18 F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with 18 F-NaF uptake being the strongest predictor.
- Open Access
- 24 October 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-7
Anatomical cardiac and electrocardiographic axes correlate in both upright and supine positions: an upright/supine CT study
The correlation between the anatomical cardiac and electrocardiographic axes has been discussed for several years. Using upright computed tomography, this study aimed to reveal the relationship between the anatomical cardiac and electrocardiographic axes in both the supine and upright positions. Upright CT and standard supine CT were performed for healthy volunteers, following electrocardiography in both upright and supine position. On CT images, the coordinates of apex, the center of aortic valve (AV) and mitral valve (MV) were recorded, and the vectors and angles were calculated. Subcutaneous and visceral fat volume were semi-automatically calculated in a workstation. From a total 190 volunteers, 41 males were performed electrocardiography and included for this study. The QRS and anatomical axes (AV-apex and MV-apex axis) were significantly correlated in both supine and upright positions, while the angle of the AV-apex to Z axis was the most correlated (supine: r = − 0.54, p = 0.0002, upright: r = − 0.47, p = 0.0020). The anatomical axis moved in the dorsal and caudal directions from the supine to upright position. Multiple regression analysis revealed that the anatomical axis from the AV-apex to the Z-axis was determined according to age, body height, subcutaneous and visceral fat volumes.
- 24 October 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-7
Open AccessAnatomical cardiac and electrocardiographic axes correlate in both upright and supine positions: an upright/supine CT study
The correlation between the anatomical cardiac and electrocardiographic axes has been discussed for several years. Using upright computed tomography, this study aimed to reveal the relationship between the anatomical cardiac and electrocardiographic axes in both the supine and upright positions. Upright CT and standard supine CT were performed for healthy volunteers, following electrocardiography in both upright and supine position. On CT images, the coordinates of apex, the center of aortic valve (AV) and mitral valve (MV) were recorded, and the vectors and angles were calculated. Subcutaneous and visceral fat volume were semi-automatically calculated in a workstation. From a total 190 volunteers, 41 males were performed electrocardiography and included for this study. The QRS and anatomical axes (AV-apex and MV-apex axis) were significantly correlated in both supine and upright positions, while the angle of the AV-apex to Z axis was the most correlated (supine: r = − 0.54, p = 0.0002, upright: r = − 0.47, p = 0.0020). The anatomical axis moved in the dorsal and caudal directions from the supine to upright position. Multiple regression analysis revealed that the anatomical axis from the AV-apex to the Z-axis was determined according to age, body height, subcutaneous and visceral fat volumes.
- 1 September 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 308 (3) , e230743
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients
Background Patients who developed myocarditis following SARS-CoV-2 vaccination show abnormalities on cardiac MRI. However, whether myocardial changes occur in asymptomatic individuals following vaccination is not well established. Purpose To assess myocardial 18Fluorine-fluorodeoxyglucose (18F-FDG) uptake on PET/CT in asymptomatic SARS-CoV-2 vaccinated patients compared to nonvaccinated patients. Materials and Methods This retrospective study included patients who underwent 18F-FDG PET/CT for indications unrelated to myocarditis during the period before (11/1/2020 - 2/16/2021) and after (2/17/20121 - 3/31/2022) SARS-CoV-2 vaccines were available. Myocardial and axillary FDG uptake were quantitatively assessed using maximum standardized uptake value (SUVmax). SUVmax values in all patients and in patients stratified by sex (male/female), age (60 years), and time interval between vaccination and PET/CT were compared using Mann-Whitney U test or Kruskal-Wallis test with post ad -hoc Dwass, Steel, Critchlow-Fligner multiple comparison analysis. Results The study included 303 nonvaccinated patients (mean age, 52.9 years ± 14.9 [SD]; 157 females) and 700 vaccinated patients (mean age, 56.8 years ± 13.7 [SD]; 344 females). Vaccinated patients had overall higher myocardial FDG uptake compared to nonvaccinated patients (median SUVmax, 4.8 [IQR: 3.0-8.5] vs median SUVmax, 3.3 [IQR: 2.5-6.2]; P < .0001). Myocardial SUVmax was higher in vaccinated patients regardless of sex (median range, 4.7-4.9 [IQR: 2.9-8.6]) or patient age (median range, 4.7-5.6 [IQR: 2.9-8.6]) compared to corresponding nonvaccinated groups (sex median range, 3.2-3.9 [IQR: 2.4-7.2]; age median range, 3.3-3.3 [IQR: 2.3-6.1]; P range, <.001-.015). Furthermore, increased myocardial FDG uptake was observed in patients imaged 1-30, 31-60, 61-120, and 121-180 days after their second vaccination (median SUVmax range, 4.6-5.1 [IQR: 2.9-8.6]) and increased ipsilateral axillary uptake was observed in patients imaged 1-30, 31-60, 61-120 days after their 2nd vaccination (median SUVmax range, 1.5-2.0 [IQR: 1.2-3.4]) compared to the nonvaccinated patients (P range, <.001-<.001). Conclusion Compared to nonvaccinated patients, asymptomatic patients who received their 2nd vaccination 1-180 days prior to imaging showed increased myocardial FDG uptake on PET/CT. See also the editorial by Bluemke in this issue.
- 1 September 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 308 (3) , e230743
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients
Background Patients who developed myocarditis following SARS-CoV-2 vaccination show abnormalities on cardiac MRI. However, whether myocardial changes occur in asymptomatic individuals following vaccination is not well established. Purpose To assess myocardial 18Fluorine-fluorodeoxyglucose (18F-FDG) uptake on PET/CT in asymptomatic SARS-CoV-2 vaccinated patients compared to nonvaccinated patients. Materials and Methods This retrospective study included patients who underwent 18F-FDG PET/CT for indications unrelated to myocarditis during the period before (11/1/2020 - 2/16/2021) and after (2/17/20121 - 3/31/2022) SARS-CoV-2 vaccines were available. Myocardial and axillary FDG uptake were quantitatively assessed using maximum standardized uptake value (SUVmax). SUVmax values in all patients and in patients stratified by sex (male/female), age (60 years), and time interval between vaccination and PET/CT were compared using Mann-Whitney U test or Kruskal-Wallis test with post ad -hoc Dwass, Steel, Critchlow-Fligner multiple comparison analysis. Results The study included 303 nonvaccinated patients (mean age, 52.9 years ± 14.9 [SD]; 157 females) and 700 vaccinated patients (mean age, 56.8 years ± 13.7 [SD]; 344 females). Vaccinated patients had overall higher myocardial FDG uptake compared to nonvaccinated patients (median SUVmax, 4.8 [IQR: 3.0-8.5] vs median SUVmax, 3.3 [IQR: 2.5-6.2]; P < .0001). Myocardial SUVmax was higher in vaccinated patients regardless of sex (median range, 4.7-4.9 [IQR: 2.9-8.6]) or patient age (median range, 4.7-5.6 [IQR: 2.9-8.6]) compared to corresponding nonvaccinated groups (sex median range, 3.2-3.9 [IQR: 2.4-7.2]; age median range, 3.3-3.3 [IQR: 2.3-6.1]; P range, <.001-.015). Furthermore, increased myocardial FDG uptake was observed in patients imaged 1-30, 31-60, 61-120, and 121-180 days after their second vaccination (median SUVmax range, 4.6-5.1 [IQR: 2.9-8.6]) and increased ipsilateral axillary uptake was observed in patients imaged 1-30, 31-60, 61-120 days after their 2nd vaccination (median SUVmax range, 1.5-2.0 [IQR: 1.2-3.4]) compared to the nonvaccinated patients (P range, <.001-<.001). Conclusion Compared to nonvaccinated patients, asymptomatic patients who received their 2nd vaccination 1-180 days prior to imaging showed increased myocardial FDG uptake on PET/CT. See also the editorial by Bluemke in this issue.
- 1 November 2022
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 53 (2) , 230-240
Vulnerable Plaque Imaging
- 1 November 2022
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 53 (2) , 230-240
Vulnerable Plaque Imaging
- 1 May 2022
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 16 (3) , 239-244
Accuracy of ultra-high–resolution computed tomography with a 0.3-mm detector for quantitative assessment of coronary artery stenosis grading in comparison with conventional computed tomography: A phantom study
- 1 May 2022
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 16 (3) , 239-244
Accuracy of ultra-high–resolution computed tomography with a 0.3-mm detector for quantitative assessment of coronary artery stenosis grading in comparison with conventional computed tomography: A phantom study
- 18 November 2019
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 28 (5) , 1936-1945
Temporal relationship between 18F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification
- 18 November 2019
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 28 (5) , 1936-1945
Temporal relationship between 18F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification
- 2 October 2018
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 45 (13) , 2250-2252
NaF uptake in unstable plaque: what does fluoride uptake mean?
- 2 October 2018
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 45 (13) , 2250-2252
NaF uptake in unstable plaque: what does fluoride uptake mean?